ArticleNature communications2025

A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD.

Jheng-Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.